SCHEMBL22985131

SCHEMBL22985131

N#Cc1ccc(-n2c3ccc(-c4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3c3cc(-c4cc(C(F)(F)F)cc(C(F)(F)F)c4)ccc32)c(-c2ccc(-c3ccc(C(F)(F)F)cc3C#N)cc2-n2c3ccc(-c4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3c3cc(-c4cc(C(F)(F)F)cc(C(F)(F)F)c4)ccc32)c1

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALOX5AP P20292 1/20 0.40
FEN1 P39748 1/20 0.40
KIF11 P52732 1/20 0.35
RXRA P19793 1/20 0.33
RXRG P48443 1/20 0.33
XDH P47989 2/20 0.33
CETP P11597 2/20 0.32
PTGDR2 Q9Y5Y4 2/20 0.31
DGAT1 O75907 1/20 0.31
SOAT1 P35610 1/20 0.31
KCNH2 Q12809 1/20 0.31
KDM1A O60341 1/20 0.31
ICMT O60725 1/20 0.31
CYP11B1 P15538 1/20 0.31
CYP11B2 P19099 1/20 0.31
STS P08842 1/20 0.30
TSHR P16473 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22985001 0.96 ALOX5AP (0.40) ALOX5APFEN1KIF11RXRARXRG
SCHEMBL20849151 0.96 ALOX5AP (0.35) ALOX5APFEN1KIF11RXRARXRG
SCHEMBL22985503 0.96 ALOX5AP (0.41) ALOX5APFEN1KIF11RXRARXRG
SCHEMBL22985064 0.96 ALOX5AP (0.41) ALOX5APFEN1KIF11RXRARXRG
SCHEMBL22985132 0.95 ALOX5AP (0.37) ALOX5APFEN1KIF11RXRARXRG
SCHEMBL22985510 0.94 ALOX5AP (0.40) ALOX5APFEN1KIF11RXRARXRG
SCHEMBL22985083 0.94 KIF11 (0.42) ALOX5APFEN1KIF11XDHPTGDR2
SCHEMBL22985508 0.94 ALOX5AP (0.42) ALOX5APFEN1KIF11XDHPTGDR2
SCHEMBL22985236 0.93 ALOX5AP (0.43) ALOX5APFEN1KIF11XDHPTGDR2
SCHEMBL20849318 0.92 STS (0.35) ALOX5APFEN1KIF11RXRARXRG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10919880-B2 Organic molecules, in particular for use in optoelectronic devices CYNORA GMBH (DE) 2021-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10919880-B2 Organic molecules, in particular for use in optoelectronic devices OCIAD1, OCIAD2, POU2F1 ALOX5AP 2567/4885FEN1 2939/4885KIF11 525/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.